AllianceBernstein’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-808,046
Closed -$31M 3217
2023
Q2
$31M Buy
808,046
+755,526
+1,439% +$29M 0.01% 725
2023
Q1
$1.22M Hold
52,520
﹤0.01% 2127
2022
Q4
$1.38M Buy
52,520
+17,400
+50% +$456K ﹤0.01% 2120
2022
Q3
$690K Hold
35,120
﹤0.01% 2486
2022
Q2
$614K Buy
35,120
+1,300
+4% +$22.7K ﹤0.01% 2588
2022
Q1
$553K Buy
33,820
+100
+0.3% +$1.64K ﹤0.01% 2621
2021
Q4
$550K Buy
33,720
+2,100
+7% +$34.3K ﹤0.01% 2687
2021
Q3
$403K Hold
31,620
﹤0.01% 2834
2021
Q2
$446K Buy
31,620
+7,400
+31% +$104K ﹤0.01% 2851
2021
Q1
$376K Hold
24,220
﹤0.01% 2796
2020
Q4
$384K Sell
24,220
-2,600
-10% -$41.2K ﹤0.01% 2714
2020
Q3
$326K Hold
26,820
﹤0.01% 2765
2020
Q2
$310K Buy
26,820
+3,120
+13% +$36.1K ﹤0.01% 2849
2020
Q1
$325K Buy
23,700
+3,440
+17% +$47.2K ﹤0.01% 2577
2019
Q4
$120K Sell
20,260
-200
-1% -$1.19K ﹤0.01% 3003
2019
Q3
$108K Sell
20,460
-680
-3% -$3.59K ﹤0.01% 3058
2019
Q2
$163K Buy
21,140
+180
+0.9% +$1.39K ﹤0.01% 3005
2019
Q1
$417K Buy
20,960
+6,660
+47% +$133K ﹤0.01% 2600
2018
Q4
$189K Buy
14,300
+1,060
+8% +$14K ﹤0.01% 2894
2018
Q3
$487K Buy
13,240
+800
+6% +$29.4K ﹤0.01% 2619
2018
Q2
$435K Sell
12,440
-4,000
-24% -$140K ﹤0.01% 2658
2018
Q1
$764K Sell
16,440
-5,820
-26% -$270K ﹤0.01% 2364
2017
Q4
$835K Buy
22,260
+13,000
+140% +$488K ﹤0.01% 2361
2017
Q3
$493K Hold
9,260
﹤0.01% 2563
2017
Q2
$528K Buy
9,260
+1,040
+13% +$59.3K ﹤0.01% 2572
2017
Q1
$442K Sell
8,220
-660
-7% -$35.5K ﹤0.01% 2560
2016
Q4
$506K Hold
8,880
﹤0.01% 2534
2016
Q3
$552K Sell
8,880
-1,180
-12% -$73.4K ﹤0.01% 2487
2016
Q2
$569K Buy
10,060
+5,300
+111% +$300K ﹤0.01% 2466
2016
Q1
$305K Buy
4,760
+1,680
+55% +$108K ﹤0.01% 2575
2015
Q4
$433K Buy
3,080
+580
+23% +$81.5K ﹤0.01% 2494
2015
Q3
$242K Sell
2,500
-200
-7% -$19.4K ﹤0.01% 2714
2015
Q2
$409K Buy
+2,700
New +$409K ﹤0.01% 2647